Volume 128, Issue 5, Pages (May 2005)

Slides:



Advertisements
Similar presentations
Novel Serum Markers of Fibrosis Progression for the Follow-Up of Hepatitis C Virus- Infected Patients  Frédérique Caillot, Martine Hiron, Odile Goria,
Advertisements

Hierarchical clustering of DEGs in Shp−/− mice, chronic hepatitis C cirrhosis, and NASH. A: unsupervised hierarchical clustering of genes common to the.
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?  Patrick Marcellin, E. Jenny Heathcote,
Volume 129, Issue 3, Pages (September 2005)
A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection 
Volume 139, Issue 4, Pages (October 2010)
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Microarray-Based Prediction of Tumor Response to Neoadjuvant Radiochemotherapy of Patients With Locally Advanced Rectal Cancer  Caroline Rimkus, Jan Friederichs,
Volume 137, Issue 1, Pages (July 2009)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 131, Issue 3, Pages (September 2006)
Volume 144, Issue 5, Pages (May 2013)
Activated glucocorticoid and eicosanoid pathways in endometriosis
Covering the Cover Gastroenterology
Volume 140, Issue 3, Pages e3 (March 2011)
Volume 139, Issue 4, Pages (October 2010)
Effectiveness of Hepatitis B Treatment in Clinical Practice
Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles  Yunao Liu, M.Sc., Kai-Fai Lee, Ph.D., Ernest H.Y.
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival  Ryan K. Van Laar 
Volume 140, Issue 3, Pages e10 (March 2011)
Volume 142, Issue 4, Pages (April 2012)
Value of Autoantibody Analysis in the Differential Diagnosis of Chronic Cholestatic Liver Disease  Piotr Milkiewicz, Hayman Buwaneswaran, Catalina Coltescu,
Volume 129, Issue 4, Pages (October 2005)
Michael Biermer, Thomas Berg  Gastroenterology 
Volume 129, Issue 3, Pages (September 2005)
Volume 136, Issue 2, Pages (February 2009)
Volume 135, Issue 4, Pages (October 2008)
Volume 154, Issue 4, Pages (March 2018)
Volume 155, Issue 5, Pages e2 (November 2018)
Jean-Michel Pawlotsky  Gastroenterology 
Treatment of hepatitis C
Effects of Etanercept Are Distinct from Infliximab in Modulating Proinflammatory Genes in Activated Human Leukocytes  Asifa S. Haider, Irma R. Cardinale,
This Month in Gastroenterology
Management of cirrhosis due to chronic hepatitis C
Microarray Analysis of Thyroid Nodule Fine-Needle Aspirates Accurately Classifies Benign and Malignant Lesions  Carrie C. Lubitz, Stacy K. Ugras, J. Jacob.
Volume 129, Issue 5, Pages (November 2005)
Effectiveness of interferon α-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice1   Thomas.
Severe Constipation Clinical Gastroenterology and Hepatology
Volume 130, Issue 3, Pages (March 2006)
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α  C.
Volume 142, Issue 6, Pages (May 2012)
Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative Colitis 
Volume 138, Issue 7, Pages (June 2010)
Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote 
Volume 138, Issue 3, Pages e3 (March 2010)
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Volume 131, Issue 2, Pages (August 2006)
Volume 129, Issue 3, Pages (September 2005)
Analysis of the Biliary Transcriptome in Experimental Biliary Atresia
Genetic Factors and Hepatitis C Virus Infection
Volume 123, Issue 4, Pages (October 2002)
Volume 134, Issue 5, Pages (May 2008)
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication  Lauren A. Beste, George.
Liver Transplantation for Hepatocellular Carcinoma
Meta-analysis Shows Extended Therapy Improves Response of Patients With Chronic Hepatitis C Virus Genotype 1 Infection  Harald Farnik, Christian M. Lange,
Volume 130, Issue 7, Pages (June 2006)
Management of Hepatitis B
Michelle Maria Pietzak  Gastroenterology 
Volume 147, Issue 6, Pages (December 2014)
Blastocyst gene expression correlates with implantation potential
Volume 141, Issue 5, Pages (November 2011)
Scott K. Fung, Anna S.F. Lok  Clinical Gastroenterology and Hepatology 
Volume 130, Issue 3, Pages (March 2006)
Controversies in Liver Transplantation for Hepatitis C
The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus.
Volume 131, Issue 5, Pages (November 2006)
Clinical Case: Chronic Constipation
Presentation transcript:

Volume 128, Issue 5, Pages 1437-1444 (May 2005) Hepatic Gene Expression Discriminates Responders and Nonresponders in Treatment of Chronic Hepatitis C Viral Infection  Limin Chen, Ivan Borozan, Jordan Feld, Jing Sun, Laura-Lee Tannis, Catalina Coltescu, Jenny Heathcote, Aled M. Edwards, Ian D. McGilvray  Gastroenterology  Volume 128, Issue 5, Pages 1437-1444 (May 2005) DOI: 10.1053/j.gastro.2005.01.059 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Real-time PCR verification of genes predicted to be altered by microarray. Real-time PCR verification was performed as described in Materials and Methods. In all cases, 4 genotype 1 R samples were compared with 4 genotype 1 NR samples and 3 normal liver samples (white, normal; gray, R; black, NR). Values along the y-axis represent the ratio, in arbitrary units, of a given gene versus β-actin. Data are expressed as mean ± SEM. *P < .05 NR versus R; Welch t test. OAS-3, P = .054; CEB-1, P = .105; RPS28, P = .053; STXBP5, P = .12. Gastroenterology 2005 128, 1437-1444DOI: (10.1053/j.gastro.2005.01.059) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Hierarchical cluster analysis using the 20 genes present in all 31 samples. Unsupervised hierarchical cluster analysis was performed as described in Materials and Methods, restricting the analysis to the 18 genes in Table 2. Red denotes an increase and green a decrease when compared with the reference RNA pool. An asterisk denotes the patients who experienced a relapse following treatment with pegylated IFN-α plus ribavirin. Note that normal liver tissue coclusters with patients who respond to treatment, while all NR samples form part of a discrete cluster. Gastroenterology 2005 128, 1437-1444DOI: (10.1053/j.gastro.2005.01.059) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 Cluster and classifier analysis using the 8-gene predictor set: all patients. (A) Hierarchical cluster analysis of all samples, restricting the analysis to the 8 genes in the predictor set. (B) KNN, LDA, and PCA of all samples using the 8-gene predictor set. Unsupervised (hierarchical cluster, PCA) and supervised (KNN, LDA) analyses were performed as described in Materials and Methods. As in Figure 2, an asterisk denotes treatment relapsers. Gastroenterology 2005 128, 1437-1444DOI: (10.1053/j.gastro.2005.01.059) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 Cluster and classifier analysis using the 8-gene classifier set: patients with genotype 1 infection only. A hierarchical cluster analysis of the 23 genotype 1 samples, restricting the analysis to the 8 genes in the predictor set. (B) KNN, LDA, and PCA of genotype 1 samples using the 8-gene predictor set. Unsupervised (hierarchical cluster, PCA) and supervised (KNN, LDA) analyses were performed as described in Materials and Methods. As in Figure 2, an asterisk denotes treatment relapsers. Gastroenterology 2005 128, 1437-1444DOI: (10.1053/j.gastro.2005.01.059) Copyright © 2005 American Gastroenterological Association Terms and Conditions